AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H1848-H1855, 2006. First published December 9, 2005; doi:10.1152/ajpheart.01033.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/H1848    most recent
01033.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prior, S. J.
Right arrow Articles by Roth, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prior, S. J.
Right arrow Articles by Roth, S. M.

DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption

Steven J. Prior,1 James M. Hagberg,1 Chad M. Paton,1 Larry W. Douglass,2 Michael D. Brown,1 John C. McLenithan,3 and Stephen M. Roth1

Departments of 1Kinesiology and of 2Animal and Avian Sciences, University of Maryland, College Park; and 3Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland

Submitted 29 September 2005 ; accepted in final form 29 November 2005

In its role as an endothelial cell proliferation and migration factor, vascular endothelial growth factor (VEGF) can affect peripheral circulation and therefore impact maximal oxygen consumption (VO2 max). Because of the role of VEGF, and because variation in the VEGF gene has the ability to alter VEGF gene expression and VEGF protein level, we hypothesized that VEGF gene polymorphisms are related to VEGF gene expression in human myoblasts and VO2 max before and after aerobic exercise training. We analyzed the effects of the VEGF –2578/–1154/–634 promoter region haplotype on VEGF gene expression by using a luciferase reporter assay in cultured human myoblasts and found that the AAG and CGC haplotypes resulted in significantly higher hypoxia-stimulated VEGF gene expression than the AGG and CGG haplotypes. Consistent with these results, we found that individuals with at least one copy of the AAG or CGC haplotype had higher VO2 max before and after aerobic exercise training than did subjects with only the AGG and/or CGG haplotype. In conclusion, we found that VEGF –2578/–1154/–634 haplotype impacts VEGF gene expression in human myoblasts and is associated with VO2 max. These results have potential implications for aerobic exercise training and may prove relevant in the study of pathological conditions that can be affected by angiogenesis, such as coronary artery disease and peripheral artery disease.

angiogenesis; exercise; genetics; polymorphism



Address for reprint requests and other correspondence: S. J. Prior, Baltimore Veterans Affairs Medical Center, Geriatrics (18), Rm. 4B-205, 10 N. Greene St., Baltimore, MD 21201 (e-mail: sprior{at}grecc.umaryland.edu)




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
D. Chalothorn, J. A. Clayton, H. Zhang, D. Pomp, and J. E. Faber
Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains
Physiol Genomics, July 18, 2007; 30(2): 179 - 191.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.